Author

A. R. Norman

Observed names: A Norman, A R Norman, A. Norman, A.R Norman, A. R. Norman

Institution: Royal Marsden Hospital

Observed institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Aberdeen Royal Infirmary, Southampton General Hospital, Derriford Hospital, Royal Brompton Hospital, Royal Marsden Hospital

ORCID: 0000-0002-2707-4056

Observed ORCID: 0000-0002-2707-4056

OpenAlex ID: A5021026207

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

2001 · H J N Andreyev, A R Norman, et al. · British Journal of Cancer · 204

Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: The REAL 2 trial

2006 · D. Cunningham, S. Rao, et al. · Journal of Clinical Oncology · 109

randomised, multicenter phase-iii study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer: Confirmation of dose escalation : 1031

2003 · Kate Sumpter, Catherine Harper‐Wynne, et al. · 25

The NUT study: the effect of dietetic and oral nutritional interventions on survival and quality of life in patients with weight loss undergoing palliative chemotherapy for gastrointestinal (GI) or lung malignancy, a randomised controlled trial

2008 · C. Baldwin, A. Spiro, et al. · Proceedings of The Nutrition Society · 6

Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex®) in advanced colorectal cancer

1998 · D.C Farrugia, A.R Norman, et al. · European Journal of Cancer · 5

The NUT study: the effect of dietetic and oral nutritional interventions on survival and quality of life in patients with weight loss undergoing palliative chemotherapy for gastrointestinal (GI) or lung malignancy, a randomised controlled trial

2008 · C. Baldwin, A. Spiro, et al. · Proceedings of The Nutrition Society · 4

A prospective randomlsed trial of protracted venous infusion (PVI) 5-FU with or without mitomycin C (MMC) in advanced colorectal cancer

1997 · P. Ross, A. Norman, et al. · European Journal of Cancer · 2

5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptable conclusion

1998 · P. Ross, A. Norman, et al. · Annals of Oncology · 1

236Hypofractionated radiotherapy for primary carcinoma of the bladder in geriatric patients

1996 · A. Horwich, C.C. Jose, et al. · Radiotherapy and Oncology · 1

The development of a preoperative chemotherapy strategy for patients selected to undergo pulmonary metastasectomy from colorectal cancer

2004 · F. Negri, A. Musolino, et al. · Journal of Clinical Oncology

2001 · I Chau, A Webb, et al. · British Journal of Cancer

The research nurses role in the study of patients recieving once weekly radiotherapy for locally advanced or recurrent rectal cancer

1999 · S. Brooker, D. Tait, et al. · European Journal of Cancer

Once weekly radiotherapy for patients with locally advanced or recurrent rectal cancer

1999 · D. Tait, J.P. Glees, et al. · European Journal of Cancer

Works count: 13

Citation count: 357

H-index: 5

I10-index: 3